Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Syndax Pharmaceuticals Inc SNDX

Healthcare Biotechnology
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease... see more

Current News (NDAQ:SNDX)

Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 5 days ago

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

GlobeNewswire 10 days ago

Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 12 days ago

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

GlobeNewswire December 12, 2025

Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum

GlobeNewswire December 8, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire December 3, 2025

Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference

GlobeNewswire December 1, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire November 5, 2025

Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 3, 2025
View More News ››

Opinion & Analysis (NDAQ:SNDX)

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Streetwise Reports February 3, 2020

2018 Biotech Watchlist: 'no one space is going to dominate'

Streetwise Reports January 11, 2018

2017 Small-Cap Biotech Watchlist update: up 21% at the end of Q2/17

The Life Sciences Report July 14, 2017

2017 Small-Cap biotech watchlist update: holding steady in a volatile market

The Life Sciences Report April 21, 2017

2017 Small-Cap Biotech Watchlist: takeaways for investors

The Life Sciences Report January 19, 2017

19 companies selected for the 2017 Small-Cap Biotech Watchlist

The Life Sciences Report January 5, 2017
View More Opinion ››

Bullboard Posts (NDAQ:SNDX)

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX): Poised for Trans

http://beyondspx.com/2024/08/01/syndax-pharmaceuticals-inc-nasdaqsndx-poised-for-transformative-growth-with-promising-pipeline-and...
MikeTester - August 1, 2024

4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

$SNDX $MTEM $STRO $KRYS Clinical-Stage companies offer an exciting investment opportunity with massive upside potential...
AviseAnalytics - October 5, 2021
View more Bullboard ››

Electrum Discovery Corp.

Electrum Discovery Corp.

Electrum Discovery Corp. engages in the acquisition and exploration of mineral properties in the natural resource sector in ...
View More »

Podcasts